Trial Profile
A Pilot Study of the Feasibility of Intraoperative Photodynamic Therapy of Glioblastoma
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Jun 2022
Price :
$35
*
At a glance
- Drugs Aminolevulinic acid (Primary)
- Indications Glioblastoma
- Focus Adverse reactions
- Acronyms INDYGO
- 03 Jun 2022 Status changed from active, no longer recruiting to completed.
- 19 Nov 2020 Planned End Date changed from 1 Dec 2019 to 1 May 2021.
- 19 Nov 2020 Planned primary completion date changed from 1 Dec 2019 to 1 May 2021.